Literature DB >> 26902451

Optimal Use of Beta-Blockers for Congestive Heart Failure.

Hae-Young Lee1, Sang Hong Baek.   

Abstract

Beta-blockers are the cornerstone treatment for congestive heart failure (HF). Current HF guidelines commonly recommend β-blockers for the treatment of HF with reduced left ventricular ejection fraction (LVEF). The effect of β-blockers, however, is less clear for HF patients with preserved LVEF, unstable severe acute HF, or right ventricular failure. This review summarizes the effect of β-blockers in various clinical situations and suggests a strategy for optimal use. (Circ J 2016; 80: 565-571).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902451     DOI: 10.1253/circj.CJ-16-0101

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  9 in total

Review 1.  Autonomic Modulation With Baroreflex Activation Therapy in Heart Failure.

Authors:  Edoardo Gronda; Emilio Vanoli
Journal:  Curr Heart Fail Rep       Date:  2016-12

2.  Cardioprotective effects of Qishen Granule () on sarcoplasmic reticulum Ca2+ handling in heart failure rats.

Authors:  Ling-Hui Lu; Chun Li; Qi-Yan Wang; Qian Zhang; Yi Zhang; Hui Meng; Yong Wang; Wei Wang
Journal:  Chin J Integr Med       Date:  2017-05-11       Impact factor: 1.978

3.  Revisiting the clinical evidence of heart rate target in patients with heart failure treated with beta-blockers.

Authors:  Xue Geng; Jidong Zhang; Yanan Zhang; Haijuan Hu; Jing Yang; Wei Cui
Journal:  Anatol J Cardiol       Date:  2021-11       Impact factor: 1.596

4.  SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis.

Authors:  Yuling Yan; Bin Liu; Jun Du; Jing Wang; Xiaodong Jing; Yajie Liu; Songbai Deng; Jianlin Du; Qiang She
Journal:  ESC Heart Fail       Date:  2021-03-21

5.  Beta Blockers in Heart Failure: More Evidence for an Old Friend.

Authors:  Sang Hong Baek
Journal:  J Korean Med Sci       Date:  2018-06-05       Impact factor: 2.153

Review 6.  Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure.

Authors:  Teruhiko Imamura; Nikhil Narang; Koichiro Kinugawa
Journal:  J Clin Med       Date:  2022-01-21       Impact factor: 4.241

7.  Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study.

Authors:  Jun-Jun Yeh; Yu-Feng Wei; Cheng-Li Lin; Wu-Huei Hsu
Journal:  BMJ Open       Date:  2017-10-05       Impact factor: 2.692

8.  Switching Therapy from Intravenous Landiolol to Transdermal Bisoprolol in a Patient with Thyroid Storm Complicated by Decompensated Heart Failure and Gastrointestinal Dysfunction.

Authors:  Shigeo Godo; Yu Kawazoe; Hiroshi Ozaki; Motoo Fujita; Daisuke Kudo; Ryosuke Nomura; Hiroaki Shimokawa; Shigeki Kushimoto
Journal:  Intern Med       Date:  2017-09-06       Impact factor: 1.271

9.  When Nothing Goes Right: Risk Factors and Biomarkers of Right Heart Failure after Left Ventricular Assist Device Implantation.

Authors:  Thomas Schlöglhofer; Franziska Wittmann; Robert Paus; Julia Riebandt; Anne-Kristin Schaefer; Philipp Angleitner; Marcus Granegger; Philipp Aigner; Dominik Wiedemann; Günther Laufer; Heinrich Schima; Daniel Zimpfer
Journal:  Life (Basel)       Date:  2022-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.